|
This bibliography of full-text articles from the biomedical literature was constructed using PubMed Central, a free digital repository created by the National Institutes of Health (NIH). The repository contains articles from both biomedical and life sciences journals and is located at
http://www.pubmedcentral.nih.gov. This is not intended to be a comprehensive listing of articles, but a “Webliography” of the most relevant of those available in the public domain.
Anthrax • Bioterrorism/Biological Warfare • Chemical Weapons/Warfare • Dengue Fever • Food Safety • Francisella Tularensis (Tularemia) • MRSA(Methicillin-Resistant Staphylococcus aureus) •
Radiological Weapons/Warfare • Variola Major (Smallpox) • Venezuelan Equine Encephalitis Virus • Viral Hemorrhagic Fevers • Yersinia Pestis/Pneumonic Plague
Anthrax
Anthrax: a continuing concern in the era of bioterrorism.
Riedel S.
roc (Bayl Univ Med Cent). 2005 Jul; 18(3): 234-243.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1200731
A silent bomb: The risk of anthrax as a weapon of mass destruction.
Webb GF.
Proc Natl Acad Sci U S A. 2003 Apr 15; 100(8): 4355-4356. published online before print April 7, 2003
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=153555
Novel Sample Preparation Method for Safe and Rapid Detection of Bacillus anthracis Spores in Environmental Powders and Nasal Swabs.
Luna VA, King D, Davis C, Rycerz T, Ewert M, Cannons A, Amuso P, Cattani J.
J Clin Microbiol. 2003 Mar; 41(3): 1252-1255.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=150283
Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak.
Brookmeyer R, Johnson E, Bollinger R.
Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17): 10129-10132. published online before print July 30, 2003
PMCID: 187789
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=187789
Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin.
Wang JY, Roehrl MH.
Med Immunol. 2005; 4: 4. published online before print March 24, 2005
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1079933
Is In Vitro Antibiotic Combination More Effective than Single-Drug Therapy against Anthrax?
Athamna A, Athamna M, Nura A, Shlyakov E, Bast DJ, Farrell D, Rubinstein E.
Antimicrob Agents Chemother. 2005 Apr; 49(4): 1323-1325.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1068588
Emergency response to an anthrax attack.
Wein LM, Craft DL, Kaplan EH.
Proc Natl Acad Sci U S A. 2003 Apr 1; 100(7): 4346-4351. published online before print March 21, 2003
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=153095
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=153095#supplementary-material-sec
In Vivo–produced Anthrax Toxin.
Fish DC, Lincoln RE.
J Bacteriol. 1968 Mar; 95(3): 919-924.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=252110
The host response to anthrax lethal toxin: unexpected observations.
Prince AS.
J Clin Invest. 2003 Sep 1; 112(5): 656-658.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=182215
Initiating informatics and GIS support for a field investigation of Bioterrorism: The New Jersey anthrax experience.
Zubieta JC, Skinner R, Dean AG.
Int J Health Geogr. 2003; 2: 8. published online before print November 16, 2003
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=293473
PATHOGENESIS OF INHALATION ANTHRAX.
Albrink WS.
Bacteriol Rev. 1961 Sep; 25(3): 268-273.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=441103
USEFUL CRITERIA FOR THE IDENTIFICATION OF BACILLUS ANTHRACIS AND RELATED SPECIES.
Burdon KL.
J Bacteriol. 1956 Jan; 71(1): 25-42.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=357732
Industrial inhalation Anthrax.
Brachman PS, Kaufman AF, Dalldorf FG.
Bacteriol Rev. 1966 Sep; 30(3): 646-659.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=378258
Bioterrorism/Biological Warfare
Bioterrorism: Implications for the Clinical Microbiologist.
Klietmann WF, Ruoff KL.
Clin Microbiol Rev. 2001 Apr; 14(2): 364-381.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=88979
Biocrimes, Microbial Forensics, and the Physician.
Schutzer SE, Budowle B, Atlas RM.
PLoS Med. 2005 Dec; 2(12): e337. published online before print September 27, 2005
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1236212
Role of the Hospital-Based Microbiology Laboratory in Preparation for and Response to a
Bioterrorism Event.
Snyder JW.
J Clin Microbiol. 2003 Jan; 41(1): 1-4.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=149646
Surge Capacity for Response to Bioterrorism in Hospital Clinical Microbiology Laboratories.
Shapiro DS.
J Clin Microbiol. 2003 Dec; 41(12): 5372-5376.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=308964
Learning about bioterrorism and chemical warfare: Medical students explore key threats.
[No authors listed]
West J Med. 2002 Jan; 176(1): 58-59.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1071656
Why global health matters to US primary care physicians.
Peabody JW, Feachem RG.
West J Med. 2001 Sep; 175(3): 153-154.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1071523
Near patient microbiological tests.
Borriello SP.
BMJ. 1999 Jul 31; 319(7205): 298-301.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1126935
Biological warfare and bioterrorism: a historical review.
Riedel S.
Proc (Bayl Univ Med Cent). 2004 Oct; 17(4): 400-406.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1200679
The problem of biological weapons.
Cole LA.
J Clin Invest. 2005 May 2; 115(5): 1110.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1087188
Bacterial toxins: a table of lethal amounts.
Gill DM.
Microbiol Rev. 1982 Mar; 46(1): 86-94.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=373212
The significance of chemical and biological warfare for the people.
Bennett IL Jr.
Proc Natl Acad Sci U S A. 1970 Jan; 65(1): 271-279.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=286221
Preparing for bioterrorism.
OReilly M.
CMAJ. 2002 May 28; 166(11): 1455.
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=111239
The Informatics Response in Disaster, Terrorism, and War.
Teich JM, Wagner MM, Mackenzie CF, Schafer BG.
J Am Med Inform Assoc. 2002; 9(2): 97-104.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=344563
Biohazard.
Charatan F.
BMJ. 1999 Oct 16; 319(7216): 1077.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1116867
Deadly Alliances: Death, Disease, and the Global Politics of Public Health.
Gandy M.
PLoS Med. 2005 Jan; 2(1): e4. published online before print January 25, 2005
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=545197
Bioterrorism: Guidelines for Medical and Public Health Management.
Reacher M.
BMJ. 2003 Mar 22; 326(7390): 665.
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1125568
AMIA Recommendations for National Health Threat Surveillance and Response.
Brennan PF.
J Am Med Inform Assoc. 2002; 9(2): 204-206.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=344578
The World Trade Center Attack: Is critical care prepared for terrorism?
Kvetan V.
Crit Care. 2001; 5(6): 321-322. published online before print November 6, 2001
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=137380
Biological warfare and bioterrorism.
Beeching NJ, Dance DA, Miller AR, Spencer RC.
BMJ. 2002 Feb 9; 324(7333): 336-339.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1122269
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1122269#supplementary-material-sec
Weapons of mass destruction—threats and responses.
Gosden C, Gardener D.
BMJ. 2005 Aug 13; 331(7513): 397-400.
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1184257
Biological warfare.
Suchard J.
West J Med. 1999 Apr; 170(4): 243.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1305563
Appropriate responses to bioterrorist threats : The health services will play a vital role in protection against covert releases.
Lightfoot N, Wale M, Spencer R, Nicoll A.
BMJ. 2001 Oct 20; 323(7318): 877-878.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1121424
Safe Food: Bacteria, biotechnology, and bioterrorism.
O’Doherty Jensen K.
J Clin Invest. 2004 Mar 15; 113(6): 787.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=362128
The problem of biological weapons.
Cole LA.
J Clin Invest. 2005 May 2; 115(5): 1110.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1087188
Response to bioterrorism : Terror weapons are regarded as weapons of mass destruction.
Lim MK.
BMJ. 2002 Feb 9; 324(7333): 362.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1122283
Chlorine Inactivation of Bacterial Bioterrorism Agents.
Rose LJ, Rice EW, Jensen B, Murga R, Peterson A, Donlan RM, Arduino MJ.
Appl Environ Microbiol. 2005 Jan; 71(1): 566-568.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=544226
Biodefense cost and consequence.
Goodman L.
J Clin Invest. 2004 Jul 1; 114(1): 2-3.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=437981
Harnessing new science is vital for biodefense and global health.
Alberts B, Fineberg HV.
Proc Natl Acad Sci U S A. 2004 Aug 3; 101(31): 11177. published online before print July 12, 2004
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=509179
The growing pains of biodefense.
Birmingham K.
J Clin Invest. 2003 Oct 1; 112(7): 970-971.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=198537
Provider and health care system response to a bioterrorist attack.
Malone JD.
Proc (Bayl Univ Med Cent). 2001 Jul; 14(3): 224-230.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1305821
Laboratory Safety Practices Associated with Potential Agents of Biocrime or Bioterrorism.
Sewell DL.
J Clin Microbiol. 2003 Jul; 41(7): 2801-2809.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=165388
Chemical Weapons/Warfare
Psychological implications of chemical and biological weapons : Long term social and psychological effects may be worse than acute ones.
Wessely S, Hyams KC, Bartholomew R.
<
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1121425
Gas and germ warfare: international legal history and present status.
Bunn G.
Proc Natl Acad Sci U S A. 1970 Jan; 65(1): 253-260.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=286219
Chemical warfare from an ecological perspective.
Lenski RE, Riley MA.
Proc Natl Acad Sci U S A. 2002 Jan 22; 99(2): 556-558.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=117343
Chemical warfare agents: toxicology and treatment.
Watson KD.
Med Hist. 1997 Apr; 41(2): 258.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1043932
Chemical weapons.
Evison D, Hinsley D, Rice P.
BMJ. 2002 Feb 9; 324(7333): 332-335.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1122267
The problem of secondary contamination following chemical agent release.
Baker D.
Crit Care. 2005; 9(4): 323-324. published online before print March 22, 2005
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1269430
Chemical Mixtures: Considering the Evolution of Toxicology and Chemical Assessment.
Monosson E.
Environ Health Perspect. 2005 Apr; 113(4): 383-390. published online before print October 21, 2004
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1278475
Dengue Fever
A model of dengue fever.
Derouich M, Boutayeb A, Twizell E.
Biomed Eng Online. 2003; 2: 4. published online before print February 19, 2003
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=153427
Dengue and Dengue Hemorrhagic Fever.
Gubler DJ.
Clin Microbiol Rev. 1998 Jul; 11(3): 480-496.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=88892
The dengue viruses.
Henchal EA, Putnak JR.
Clin Microbiol Rev. 1990 Oct; 3(4): 376-396.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=358169
Current Advances in Dengue Diagnosis.
Shu PY, Huang JH.
Clin Diagn Lab Immunol. 2004 Jul; 11(4): 642-650.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=440621
Dengue: defining protective versus pathologic immunity.
Rothman AL.
J Clin Invest. 2004 Apr 1; 113(7): 946-951.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=379334
Dengue fever: new paradigms for a changing epidemiology.
Guha-Sapir D, Schimmer B.
Emerg Themes Epidemiol. 2005; 2: 1. published online before print March 2, 2005
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=555563
Food Safety
The Role of internists during epidemics, outbreaks, and bioterrorist attacks.
Lee BY. J Gen Intern Med. 2007 January; 22(1): 131–136. Published online 2007 January 13.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1824729&blobtype=pdf
The color of hamburger: slow steps toward the development of a science-based food safety system in the United States.
Morris JG, Jr.
Trans Am Clin Climatol Assoc. 2003; 114: 191–202.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=2194493&blobtype=pdf
Laboratory safety practices associated with potential agents of biocrime or bioterrorism.
Sewell DL.
J Clin Microbiol. 2003 July; 41(7): 2801–2809. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=165388&blobtype=pdf
Benefits of linking public health, animal health, and food safety surveillance.
Mann E.
Can Vet J. 2002 October; 43(10): 796–797. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=339620&blobtype=pdf
Mycotoxins.
Bennett JW, Klich M.
Clin Microbiol Rev. 2003 July; 16(3): 497–516. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=164220&blobtype=pdf
Implications of the World Trade Center attack for the public health and health care infrastructures.
Klitzman S, Freudenberg N.
Am J Public Health. 2003 March; 93(3): 400–406.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1447752&blobtype=pdf
Availability and perceived effectiveness of public health activities in the nation’s most populous communities.
Mays GP, Halverson PK, Baker EL, Stevens R, Vann JJ.
Am J Public Health. 2004 June; 94(6): 1019–1026.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1448383&blobtype=pdf
The threat of things biological.
VanderMeer DC.
Environ Health Perspect. 1998 June; 106(6): A280–A282.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1533003&blobtype=pdf
Food safety and foodborne disease in 21st century homes.
Scott E.
Can J Infect Dis. 2003 Sep–Oct; 14(5): 277–280.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=2094945&blobtype=pdf
Making food safety an issue: internationalized food politics and French public health from the 1870s to the present.
Zylberman P.
Med Hist. 2004 January 1; 48(1): 1–28.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=546293&blobtype=pdf
Investigation of multistate foodborne disease outbreaks.
Sobel J, Griffin PM, Slutsker L, Swerdlow DL, Tauxe RV.
Public Health Rep. 2002 Jan–Feb; 117(1): 8–19.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1497402&blobtype=pdf
Francisella Tularensis (Tularemia)
STUDIES ON TULAREMIA: II. The Antigenic Properties of Variants of Pasteurella tularensis in Various Hosts.
Downs CM, Moody MD.
J Bacteriol. 1955 Sep; 70(3): 305-313.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=357686
STUDIES ON TULAREMIA: I. The Relation Between Certain Pathogenic and Immunogenic Properties of Variants of Pasteurella tularensis.
Moody MD, Downs CM.
J Bacteriol. 1955 Sep; 70(3): 297-304.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=357685
TULAREMIA.
Levin W.
Bull Med Libr Assoc. 1940 Oct; 29(1): 17-22.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=233540
Francisella tularensis Bacteremia.
Haristoy X, Lozniewski A, Tram C, Simeon D, Bevanger L, Lion C.
J Clin Microbiol. 2003 Jun; 41(6): 2774-2776.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=156490
Antibiotic prophylaxis and therapy of airborne tularemia.
Sawyer WD, Dangerfield HG, Hogge AL, Crozier D.
Bacteriol Rev. 1966 Sep; 30(3): 542-550.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=378237
Bactericidal Activities of Antibiotics against Intracellular Francisella tularensis.
Maurin M, Mersali NF, Raoult D.
Antimicrob Agents Chemother. 2000 Dec; 44(12): 3428-3431.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=90216
Tularemia.
Ellis J, Oyston PC, Green M, Titball RW.
Clin Microbiol Rev. 2002 Oct; 15(4): 631-646.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=126859
STUDIES ON TULAREMIA: III. The Variation of Pasteurella tularensis Grown in the Presence of Normal and Immune Serum from Various Hosts.
Moody MD.
J Bacteriol. 1955 Sep; 70(3): 314-319.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=357687
MRSA (Methicillin-Resistant Staphylococcus aureus)
Methicillin-Resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA Direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs.
van Hal SJ, Stark D, Lockwood B, Marriott D, Harkness J.
J Clin Microbiol. 2007 August; 45(8): 2486–2490. Published online 2007 May 30.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1951204&blobtype=pdf
Community-Acquired Methicillin-Resistant Staphylococcus aureus: prevalence and risk factors.
Beam JW,Buckley B.
J Athl Train. 2006; 41(3): 337–340.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1569547&blobtype=pdf
Combined use of Pastorex Staph-Plus and either of two new chromogenic agars, MRSA ID and CHROMagar MRSA, for detection of Methicillin-Resistant Staphylococcus aureus.
Compernolle V, Verschraegen G, Claeys G.
J Clin Microbiol. 2007 January; 45(1): 154–158. Published online 2006 November 8.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1828984&blobtype=pdf
The Increasing problem of wound bacterial burden and infection in acute and chronic soft-tissue wounds caused by Methicillin-Resistant Staphylococcus aureus.
Demling RH, Waterhouse B.
J Burns Wounds. 2007; 7: e8. Published online 2007 November 16.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=2104747&blobtype=pdf
Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomised crossover trial.
Jeyaratnam D, Whitty CJM, Phillips K, Liu D, Orezzi C, Ajoku U, French GL.
BMJ. 2008 April 26; 336(7650): 927–930. Published online 2008 April 16.
http://www.bmj.com/cgi/reprint/336/7650/927
Epidemiology of emerging Methicillin-Resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection.
Faria NA, Oliveira DC, Westh H, Monnet DL, Larsen AR, Skov R, de Lencastre H.
J Clin Microbiol. 2005 April; 43(4): 1836–1842. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1081382&blobtype=pdf
Comparisons of community-associated Methicillin-Resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California.
Huang H, Flynn NM, King JH, Monchaud C, Morita M, Cohen SH.
J Clin Microbiol. 2006 July; 44(7): 2423–2427. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1489486&blobtype=pdf
Mortality after infection with methicillin-resistant Staphylococcus aureus (MRSA) diagnosed in the community.
Delaney JA, Schneider-Lindner V, Brassard P, Suissa S.
BMC Med. 2008; 6: 2. Published online 2008 January 31. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=2259374&blobtype=pdf
Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study.
Harbarth S, Masuet-Aumatell C, Schrenzel J, Francois P, Akakpo C, Renzi G, Pugin J, Ricou B, Pittet D.
Crit Care. 2006; 10(1): R25. Published online 2006 February 6. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1550853&blobtype=pdf
Risk factors and molecular analysis of community methicillin-resistant Staphylococcus aureus carriage.
Lu PL, Chin LC, Peng CF, Chiang YH, Chen TP, Ma L, Siu LK.
J Clin Microbiol. 2005 January; 43(1): 132–139. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=540160&blobtype=pdf
A study of the efficacy and cost-effectiveness of MRSA screening and monitoring on surgical wards using a new, rapid molecular test (EMMS).
Hardy KJ, Szczepura A, Davies R, Bradbury A, Stallard N, Gossain S, Walley P, Hawkey PM.
BMC Health Serv Res. 2007; 7: 160. Published online 2007 October 3.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=2093934&blobtype=pdf
New real-time PCR assay for rapid detection of Methicillin- Resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci.
Huletsky A, Giroux R, Rossbach V, Gagnon M, Vaillancourt M, Bernier M, Gagnon F, Truchon K, Bastien M, Picard FJ, van Belkum A, Ouellette M, Roy PH, Bergeron mG.
J Clin Microbiol. 2004 May; 42(5): 1875–1884. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=404602&blobtype=pdf
Evaluation of BacLite Rapid MRSA, a rapid culture based screening test for the detection of ciprofloxacin and methicillin resistant S. aureus (MRSA) from screening swabs.
Johnson G, Millar MR, Matthews S, Skyrme M, Marsh P, Barringer E, O'Hara S, Wilks M.
BMC Microbiol. 2006; 6: 83. Published online 2006 September 29. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1592303&blobtype=pdf
The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)
Enright MC, D. Robinson A, Randle G, Feil EJ, Grundmann H, Spratt BG.
Proc Natl Acad Sci U S A. 2002 May 28; 99(11): 7687–7692. Published online 2002 May 21.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=124322&blobtype=pdf
Role of previous hospitalization in clinically-significant MRSA infection among HIV-infected inpatients: results of a case-control study.
Drapeau CMJ, Angeletti C, Festa A, Petrosillo N
BMC Infect Dis. 2007; 7: 36. Published online 2007 April 30. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1868735&blobtype=pdf
Methicillin-Resistant Staphylococcus aureus infection or colonization present at hospital admission: multivariable risk factor screening to increase efficiency of surveillance culturing.
Haley CC, Mittal D, LaViolette A, Jannapureddy S, Parvez N, Haley RW.
J Clin Microbiol. 2007 September; 45(9): 3031–3038. Published online 2007 July 11.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=2045295&blobtype=pdf
Targeted intranasal Mupirocin to prevent colonization and infection by community-associated Methicillin-Resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.
Ellis MW, Griffith ME, Dooley DP, McLean JC, Jorgensen JH, Patterson JE, Davis KA, Hawley JS, Regules JA, Rivard RG, Gray PJ, Ceremuga JM, DeJoseph MA, Hospenthal DR.
Antimicrob Agents Chemother. 2007 October; 51(10): 3591–3598. Published online 2007 August 6.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=2043273&blobtype=pdf
Trends in prescribing β-Lactam antibiotics for treatment of community-associated Methicillin-Resistant Staphylococcus aureus infections.
Gupta K, MacIntyre A, Vanasse G, Dembry LM.
J Clin Microbiol. 2007 December; 45(12): 3930–3934. Published online 2007 October 17.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=2168566&blobtype=pdf
Treatment and outcomes of infections by Methicillin-Resistant Staphylococcus aureus at an ambulatory clinic.
Szumowski JD, Cohen DE, Kanaya F, Mayer KH.
Antimicrob Agents Chemother. 2007 February; 51(2): 423–428. Published online 2006 November 20.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1797761&blobtype=pdf
Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000–2003, increasing incidence and regional differences.
Stenhem M, Örtqvist A, Ringberg H, Larsson L, Olsson-Liljequist B, Hæggman S, Ekdahl K, and The Swedish Study Group on MRSA Epidemiology.
BMC Infect Dis. 2006; 6: 30. Published online 2006 February 21. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1459167&blobtype=pdf
Methicillin-resistant Staphylococcus aureus in a general intensive care unit.
Thompson DS.
J R Soc Med. 2004 November; 97(11): 521–526.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1079644&blobtype=pdf
Epidemiology and outcomes of community-associated Methicillin-Resistant Staphylococcus aureus infection.
Davis SL, Perri MB, Donabedian SM, Manierski C, Singh A, Vager D, Haque NZ, Speirs K, Muder RR, Robinson-Dunn B, Hayden MK, Zervos MJ.
J Clin Microbiol. 2007 June; 45(6): 1705–1711. Published online 2007 March 28.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1933099&blobtype=pdf
The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.
Simor AE, Loeb M, and CIDS/CAMM Guidelines Committee.
Can J Infect Dis. 2004 Jan–Feb; 15(1): 39–48.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=2094920&blobtype=pdf
Emergence and spread of community-associated Methicillin-Resistant Staphylococcus aureus in rural Wisconsin, 1989 to 1999.
Stemper ME, Shukla SK, Reed KD.
J Clin Microbiol. 2004 December; 42(12): 5673–5680.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=535270&blobtype=pdf
Radiological Weapons/Warfare
Teratogenicity of depleted uranium aerosols: A review from an epidemiological perspective.
Hindin R, Brugge D, Panikkar B.
Environ Health. 2005; 4: 17. published online before print August 26, 2005
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1242351
Radiological weapons: what type of threat?
Mapstone J, Brett S.
Crit Care. 2005; 9(3): 223-225. published online before print February 17, 2005
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1175869
Variola Major (Smallpox)
The smallpox story: life and death of an old disease.
Behbehani AM.
Microbiol Rev. 1983 Dec; 47(4): 455-509.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=281588
Bioterrorism Preparedness: The Smallpox Vaccine Debate.
Qutaishat SS, Olson JL.
Clin Med Res. 2003 Apr; 1(2): 85-86.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1069028
Edward Jenner and the history of smallpox and vaccination.
Riedel S.
Proc (Bayl Univ Med Cent). 2005 Jan; 18(1): 21-25.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1200696
Large-Scale Screening of Nasal Swabs for Bacillus anthracis: Descriptive Summary and Discussion of the National Institutes of Health's Experience.
Kiratisin P, Fukuda CD, Wong A, Stock F, Preuss JC, Ediger L, Brahmbhatt TN, Fischer SH, Fedorko DP, Witebsky FG, Gill VJ.
J Clin Microbiol. 2002 Aug; 40(8): 3012-3016.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=120640
Smallpox and biological warfare: a disease revisited.
Riedel S.
Proc (Bayl Univ Med Cent). 2005 Jan; 18(1): 13-20.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1200695
Smallpox Vaccine: The Good, the Bad, and the Ugly.
Belongia EA, Naleway AL.
Clin Med Res. 2003 Apr; 1(2): 87-92.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1069029
Discovery of antivirals against smallpox.
Harrison SC, Alberts B, Ehrenfeld E, Enquist L, Fineberg H, McKnight SL, Moss B, O'Donnell M, Ploegh H, Schmid SL, Walter KP, Theriot J.
Proc Natl Acad Sci U S A. 2004 Aug 3; 101(31): 11178-11192. published online before print July 12, 2004
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=509180
Bioterrorism Preparedness: The Smallpox Vaccine Debate.
Qutaishat SS, Olson JL.
Clin Med Res. 2003 Apr; 1(2): 85-86.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1069028
Emergency response to a smallpox attack: The case for mass vaccination.
Kaplan EH, Craft DL, Wein LM.
Proc Natl Acad Sci U S A. 2002 Aug 6; 99(16): 10935-10940. published online before print July 12, 2002
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=125076
The poxviruses.
Joklik WK.
Bacteriol Rev. 1966 Mar; 30(1): 33-66.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=378213
BIOLOGICALS FOR THE CONTROL AND THERAPY OF VIRUS DISEASES.
Murray R.
Bacteriol Rev. 1964 Dec; 28(4): 493-496.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=441250
Venezuelan Equine Encephalitis Virus
Emergence of a new epidemic/epizootic Venezuelan equine encephalitis virus in South America.
Rico-Hesse R, Weaver SC, de Siger J, Medina G, Salas RA.
Proc Natl Acad Sci U S A. 1995 Jun 6; 92(12): 5278-5281.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=41677
Preparation and testing of vaccines prepared from the envelopes of Venezuelan, eastern, and western equine encephalomyelitis viruses.
Pedersen CE Jr.
J Clin Microbiol. 1976 Feb; 3(2): 113-118.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=274245
Effect of Relative Humidity and Temperature on Airborne Venezuelan Equine Encephalitis Virus.
Ehrlich R, Miller S.
Appl Microbiol. 1971 Aug; 22(2): 194-199.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=377412
Estimating downwind concentrations of viable airborne microorganisms in dynamic atmospheric conditions.
Lighthart B, Mohr AJ.
Appl Environ Microbiol. 1987 Jul; 53(7): 1580-1583.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=203913
Virological and serological studies of Venezuelan equine encephalomyelitis in humans.
Bowen GS, Calisher CH.
J Clin Microbiol. 1976 Jul; 4(1): 22-27.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=274383
Stability of Live Attenuated Venezuelan Equine Encephalitis Vaccine.
McManus AT, Robinson DM.
Appl Microbiol. 1972 Mar; 23(3): 654-655.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=380402
Biological Transmission of Arboviruses: Reexamination of and New Insights into Components, Mechanisms, and Unique Traits as Well as Their Evolutionary Trends.
Kuno G, Chang GJ.
Clin Microbiol Rev. 2005 Oct; 18(4): 608-637.
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1265912
The alphaviruses: gene expression, replication, and evolution.
Strauss JH, Strauss EG.
Microbiol Rev. 1994 Sep; 58(3): 491-562.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=372977
Epidemiological Aspects of Venezuelan Equine Encephalitis Virus Infections.
Sidwell RW, Gebhardt LP, Thorpe BD.
Bacteriol Rev. 1967 Mar; 31(1): 65-81.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=441023
Medically important arboviruses of the United States and Canada.
Calisher CH.
Clin Microbiol Rev. 1994 Jan; 7(1): 89-116.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=358307
Purification, Concentration, and Inactivation of Venezuelan Equine Encephalitis Virus.
Gruber J.
Appl Microbiol. 1970 Sep; 20(3): 427-432.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=376952
Viral Hemorrhagic Fevers – Ebola Virus, Rift Valley Fever, Hantaavirus, Marburg Virus, Lassa Fever
Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection.
Maruyama T, Rodriguez LL, Jahrling PB, Sanchez A, Khan AS, Nichol ST, Peters CJ, Parren PW, Burton DR.
J Virol. 1999 Jul; 73(7): 6024-6030.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=11266
Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease.
Schnittler HJ, Mahner F, Drenckhahn D, Klenk HD, Feldmann H.
J Clin Invest. 1993 Apr; 91(4): 1301-1309.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=288099
Ebola virus-like particles protect from lethal Ebola virus infection.
Warfield KL, Bosio CM, Welcher BC, Deal EM, Mohamadzadeh M, Schmaljohn A, Aman MJ, Bavari S.
Proc Natl Acad Sci U S A. 2003 Dec 23; 100(26): 15889-15894. published online before print December 12, 2003
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=307663
Persistent Infection with Ebola Virus under Conditions of Partial Immunity.
Gupta M, Mahanty S, Greer P, Towner JS, Shieh WJ, Zaki SR, Ahmed R, Rollin PE.
J Virol. 2004 Jan; 78(2): 958-967.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=368745
Effective Vaccine for Lassa Fever.
Fisher-Hoch SP, Hutwagner L, Brown B, McCormick JB.
J Virol. 2000 Aug; 74(15): 6777-6783.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=112194
Vertical transmission of viruses.
Mims CA.
Microbiol Rev. 1981 Jun; 45(2): 267-286.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=281509
Wave-Like Spread of Ebola Zaire.
Walsh PD, Biek R, Real LA.
PLoS Biol. 2005 Nov; 3(11): e371. published online before print October 25, 2005
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1262627
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1262627#supplementary-material-sec
Passive Immunity in Prevention and Treatment of Infectious Diseases.
Keller MA, Stiehm ER.
Clin Microbiol Rev. 2000 Oct; 13(4): 602-614.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=88952
Development of a New Vaccine for the Prevention of Lassa Fever.
Geisbert TW, Jones S, Fritz EA, Shurtleff AC, Geisbert JB, Liebscher R, Grolla A, Ströher U, Fernando L, Daddario KM, Guttieri MC, Mothé BR, Larsen T, Hensley LE, Jahrling PB, Feldmann H.
PLoS Med. 2005 Jun; 2(6): e183. published online before print June 28, 2005
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1160587
Ebola Virus Pathogenesis: Implications for Vaccines and Therapies.
Sullivan N, Yang ZY, Nabel GJ.
J Virol. 2003 Sep; 77(18): 9733-9737.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=224575
Marburg and Ebola Virus Infections: A Guide for their Diagnosis, Management, and Control.
Grist NR.
J Clin Pathol. 1978 May; 31(5): 503.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1145319
Rapid Detection and Quantification of RNA of Ebola and Marburg Viruses, Lassa Virus, Crimean-Congo Hemorrhagic Fever Virus, Rift Valley Fever Virus, Dengue Virus, and Yellow Fever Virus by Real-Time Reverse Transcription-PCR.
Drosten C, Göttig S, Schilling S, Asper M, Panning M, Schmitz H, Günther S.
J Clin Microbiol. 2002 Jul; 40(7): 2323-2330.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=120575
Containing the Threat—Don't Forget Ebola.
Cohen J.
PLoS Med. 2004 Dec; 1(3): e59. published online before print December 28, 2004
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=539049
Emerging infections--Ebola and other filoviruses.
Peters CJ.
West J Med. 1996 Jan; 164(1): 36-38.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1303291
Emerging viral diseases.
Nichol ST, Arikawa J, Kawaoka Y.
Proc Natl Acad Sci U S A. 2000 Nov 7; 97(23): 12411-12412. published online before print October 17, 2000
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=34064
Vaccine protects against Ebola virus.
Josefson D.
BMJ. 2000 Dec 9; 321(7274): 1433.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1173511
ASPECTS OF THE PATHOGENESIS OF VIRUS DISEASES.
Mims CA.
Bacteriol Rev. 1964 Mar; 28(1): 30-71.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=441209
Immunological Methods for Detection and Identification of Infectious Disease and Biological Warfare Agents.
Peruski AH, Peruski, Jr. LF.
Clin Diagn Lab Immunol. 2003 Jul; 10(4): 506-513.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=164256
Nosocomial Spread of Viral Disease.
Aitken C, Jeffries DJ.
Clin Microbiol Rev. 2001 Jul; 14(3): 528-546.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=88988
Mechanisms of virus pathogenicity.
Smith H.
Bacteriol Rev. 1972 Sep; 36(3): 291-310.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=378451
Assessment of Aerosol Mixtures of Different Viruses.
Mayhew CJ, Hahon N.
Appl Microbiol. 1970 Sep; 20(3): 313-316.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=376931
Pathogenesis of rashes in virus diseases.
Mims CA.
Bacteriol Rev. 1966 Dec; 30(4): 739-760.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=441013
Monoclonal antibodies specific for Hantaan virus.
Franko MC, Gibbs CJ Jr, Lee PW, Gajdusek DC.
Proc Natl Acad Sci U S A. 1983 Jul; 80(13): 4149-4153.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=394218
A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses.
Hjelle B, Jenison S, Torrez-Martinez N, Yamada T, Nolte K, Zumwalt R, MacInnes K, Myers G.
J Virol. 1994 Feb; 68(2): 592-596.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=236491
Yersinia Pestis/Pneumonic Plague
Microevolution and history of the plague bacillus, Yersinia pestis.
Achtman M, Morelli G, Zhu P, Wirth T, Diehl I, Kusecek B, Vogler AJ, Wagner DM, Allender CJ, Easterday WR, Chenal-Francisque V, Worsham P, Thomson NR, Parkhill J, Lindler LE, Carniel E, Keim P.
Proc Natl Acad Sci U S A. 2004 Dec 21; 101(51): 17837-17842. published online before print December 14, 2004
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=535704
Identifying Sources of Human Exposure to Plague.
Lowell JL, Wagner DM, Atshabar B, Antolin MF, Vogler AJ, Keim P, Chu MC, Gage KL.
J Clin Microbiol. 2005 Feb; 43(2): 650-656.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=548095
Yersinia pestis--etiologic agent of plague.
Perry RD, Fetherston JD.
Clin Microbiol Rev. 1997 Jan; 10(1): 35-66.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=172914
Survival of Yersinia pestis on Environmental Surfaces.
Rose LJ, Donlan R, Banerjee SN, Arduino MJ.
Appl Environ Microbiol. 2003 Apr; 69(4): 2166-2171.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=154802
Detection of Yersinia pestis in Sputum by Real-Time PCR.
Loïez C, Herwegh S, Wallet F, Armand S, Guinet F, Courcol RJ.
J Clin Microbiol. 2003 Oct; 41(10): 4873-4875.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=254301
Molecular and cell biology aspects of plague.
Cornelis GR.
Proc Natl Acad Sci U S A. 2000 Aug 1; 97(16): 8778-8783.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=34011
Factors promoting acute and chronic diseases caused by yersiniae.
Brubaker RR.
Clin Microbiol Rev. 1991 Jul; 4(3): 309-324.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=358201
Plague: from natural disease to bioterrorism.
Riedel S.
Proc (Bayl Univ Med Cent). 2005 Apr; 18(2): 116-124.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1200711
The Yersinia Deadly Kiss.
Cornelis GR.
J Bacteriol. 1998 Nov; 180(21): 5495-5504.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=107605
Plague The mysterious past and terrifying future of the world’s most deadly disease.
Wren B.
J Clin Invest. 2005 Jan 3; 115(1): 4.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=539310
Plague: a continuing threat.
Weir E.
CMAJ. 2005 Jun 7; 172(12): 1555.
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=558167
The Plague Race: A Tale of Fear, Science and Heroism.
Murdoch DR.
BMJ. 2002 Oct 19; 325(7369): 909.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1124411
Winter, plague and pestilence.
Petsko GA.
Genome Biol. 2001; 2(11): comment1013.1-comment1013.2. published online before print October 23, 2001
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=138975
The great plague.
Martensen R.
Med Hist. 2001 Jul; 45(3): 431-433.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1044411
The Black Death: a biological reappraisal.
Wilkinson L.
Med Hist. 1985 Jul; 29(3): 326-328.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1139550
Plague: from natural disease to bioterrorism.
Riedel S.
Proc (Bayl Univ Med Cent). 2005 Apr; 18(2): 116-124.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1200711
PNEUMONIC PLAGUE.
Meyer KF.
Bacteriol Rev. 1961 Sep; 25(3): 249-261.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=441101
Antiviral therapy: current concepts and practices.
Bean B.
Clin Microbiol Rev. 1992 Apr; 5(2): 146-182.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=358233
a
Plague The mysterious past and terrifying future of the world’s most deadly disease.
Wren B.
J Clin Invest. 2005 Jan 3; 115(1): 4.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=539310
Plague--perspectives on a rare disease.
Mann J.
West J Med. 1984 Apr; 140(4): 650-651.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1021813
Control of plague.
Werner SB, Roberto RR, Nelson BC, Bissett M.
West J Med. 1979 Mar; 130(3): 271-273.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1238603
Molecular and cell biology aspects of plague.
Cornelis GR.
Proc Natl Acad Sci U S A. 2000 Aug 1; 97(16): 8778-8783.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=34011
The Plague Race: A Tale of Fear, Science and Heroism.
Murdoch DR.
BMJ. 2002 Oct 19; 325(7369): 909.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1124411
Mechanisms of virus pathogenicity.
Smith H.
Bacteriol Rev. 1972 Sep; 36(3): 291-310.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=378451
Classic Descriptions of Disease.
[No authors listed]
Can Med Assoc J. 1932 Oct; 27(4): 458.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=536441
MECHANISMS OF MAN'S RESISTANCE TO INFECTIOUS DISEASES.
Nungester WJ.
Bacteriol Rev. 1951 Sep; 15(3): 105-129.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=440981
Identifying Sources of Human Exposure to Plague.
Lowell JL, Wagner DM, Atshabar B, Antolin MF, Vogler AJ, Keim P, Chu MC, Gage KL.
J Clin Microbiol. 2005 Feb; 43(2): 650-656.
http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=548095
|
